title: Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with CKD and their families.
abstract: This cross-sectional study measured patient and family member reported treatment and economic burden associated with monthly versus weekly erythropoiesis stimulating protein therapies for anemia in patients with CKD who were not yet on dialysis. The results indicated that compared to a weekly regimen, a monthly regimen saved patients 7 hours and family members 19 hours per month for routine anemia management. The monthly regimen substantially reduced the reported economic and treatment burdens of patient and their family members.
authors.affiliation: Global Health Economics & Outcomes Research, Amgen Inc., Thousand Oaks, CA, USA. dglobe@amgen.com
authors.forename: Denise
authors.initials: D
authors.lastname: Globe
authors.forename: Deborah
authors.initials: D
authors.lastname: Glidden
authors.forename: Joachim
authors.initials: J
authors.lastname: Hertel
authors.forename: Joele
authors.initials: J
authors.lastname: Thomas
authors.forename: Michele
authors.initials: M
authors.lastname: Ackerman
authors.forename: Felicia
authors.initials: F
authors.lastname: Chidolue
authors.forename: Bianca
authors.initials: B
authors.lastname: Blanco
authors.forename: Annette
authors.initials: A
authors.lastname: Borden
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Goss
authors.forename: Xiao
authors.initials: X
authors.lastname: Xu
authors.forename: Reshma
authors.initials: R
authors.lastname: Kewalramani
mesh_terms: D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004334:Drug Administration Schedule; D004920:Erythropoiesis; D004921:Erythropoietin / Q000008:administration & dosage*; D005190:Family / Q000523:psychology*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011795:Surveys and Questionnaires
chemical_list: D004921:Erythropoietin